Highmark Commercial Medical Policy - Pennsylvania |
Medical Policy: | R-90-002 |
Topic: | Radiation Therapy for Non-malignant Disease |
Section: | Radiation Therapy & Nuclear Medicine |
Effective Date: | August 1, 2018 |
Issue Date: | July 30, 2018 |
Last Reviewed: | May 2018 |
Benign disorders do not always follow a benign course, so radiation was employed for many conditions for which there was no suitable therapeutic alternative. As improvements in competing therapies have been developed, such as antibiotics, antifungals, antivirals, chemotherapies, improved surgical techniques, and immunological therapy, radiation therapy is no longer appropriate for many disorders, yet has become the preferred therapy for others. |
This policy is designed to address medical guidelines that are appropriate for the majority of individuals with a particular disease, illness, or condition. Each person's unique clinical circumstances may warrant individual consideration, based on review of applicable medical records.
Policy Position Coverage is subject to the specific terms of the member’s benefit plan. |
Non-malignant disorders for which radiation therapy may be considered medically necessary when criteria are met:
Non-malignant disorders for which radiation therapy may be considered medically necessary when criteria are met:
Note: all requests require review on a case-by-case basis
Non-malignant disorders for which radiation therapy is considered experimental/investigational, and therefore, non-covered because the safety and/or effectiveness of this service cannot be established by the available published peer-reviewed literature:
Refer to medical policy R-95 Radiation Therapy for Skin Cancer for additional information. |
Place of Service: Outpatient |
Radiation therapy for non-malignant diseases is typically an outpatient procedure which is only eligible for coverage as an inpatient procedure in special circumstances, including, but not limited to, the presence of a co-morbid condition that would require monitoring in a more controlled environment such as the inpatient setting.
The policy position applies to all commercial lines of business |
Denial Statements |
Services that do not meet the criteria of this policy will not be considered medically necessary. A network provider cannot bill the member for the denied service unless: (a) the provider has given advance written notice, informing the member that the service may be deemed not medically necessary; (b) the member is provided with an estimate of the cost; and (c) the member agrees in writing to assume financial responsibility in advance of receiving the service. The signed agreement must be maintained in the provider’s records.
Services that do not meet the criteria of this policy will be considered experimental/investigational (E/I). A network provider can bill the member for the experimental/investigational service. The provider must give advance written notice informing the member that the service has been deemed E/I. The member must be provided with an estimate of the cost and the member must agree in writing to assume financial responsibility in advance of receiving the service. The signed agreement must be maintained in the provider’s records.
Links |
05/2018, REMINDER: Radiation Therapy
01/2018, REMINDER: Radiation Therapy